The European Journal of  Paeditric Neurology recently published a study stating that 17 children with intractable spastic cerebral palsy exhibited relief from pain, improved mental health and easier care following continuous infusion of intrathecal baclofen at 12 and 24 months.

Reference:  Marjanke A. Hoving, Elisabeth P.M. van Raak, Geert H.J.J. Spincemaille et al.  (2008) Safety and one-year efficacy of intrathecal baclofen therapy in children with intractable spastic cerebral palsy.  European Journal of Paeditric Neurology doi:10.1016/j.ejpn.2008.05.002  

Go to www.YourTherapySource.com homepage